LINC01764

Across TCGA pan-cancer cohorts, LINC01764 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated LINC01764 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher LINC01764 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01764 expression acts as an unfavorable survival marker, although some lineages such as UVM and CESC show a favorable association.

HNSC, UVM, and COAD are the cancer types where LINC01764 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	All	0.524	0.665	<.001	135	view →
UVM	DFS	Tertile	II,III,IV	0.760	0.398	.001	79	view →
COAD	OS	Quartile	All	0.477	0.662	<.001	70	view →
CESC	OS	Median	IV	0.663	0.107	.010	56	view →
MESO	DFS	Median	All	0.395	0.191	.002	45	view →
LAML	DFS	Median	All	0.718	0.419	.003	34	view →
THCA	OS	Tertile	IV	0.720	1.000	.004	27	view →
THYM	OS	Quartile	III,IV	0.480	1.000	.003	26	view →
UCS	DFS	Tertile	IV	0.835	0.237	.024	24	view →
STAD	DFS	Median	II,III,IV	0.381	0.596	.007	24	view →
KIRP	DFS	Tertile	IV	0.170	0.489	.004	24	view →
LUSC	DFS	Tertile	III,IV	0.135	0.751	.009	22	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

LINC01764–HNSC (DFS)

Open the HNSC breakdown →